Carlsmed Inc (CARL) - רווח נקי למניה (EPS TTM)

Cheryl Blanchar's team at Carlsmed Inc (CARL) effectively attracts investment and engages with regulators. The 12-month rolling earnings per share history demonstrates volatility, while -1.47 records a new level. Transparent management facilitates sales growth, and the implementation of the Aprevo AI platform for 3D-printed implants ensures technological leadership in the high-precision spinal surgery segment.
CARL (Carlsmed Corp): פילוחים אנליטיים ודוחות לפי אינדיקטורים

This indicator reflects the adjusted annual earnings per share, allowing investors to assess the real efficiency of capital without distortions from one-time operations. When analyzing the 12-month EPS trend chart, one should correlate profit growth rates with the scaling of B2B sales of AI implants for neurosurgery, which confirms the commercial viability of the high-tech 3D printing of Carlsmed Inc (CARL).